ZoomMed inc. (TSX VENTURE: ZMD). At the annual shareholders' meeting of ZoomMed Corporation, the President and CEO, Mr. Yves Marmet, announced a number of decisions having a significant impact for the future of the Corporation.
"We have every reason to be confident in the future of ZoomMed" declared Mr. Marmet. "More and more family doctors, pharmacists and pharmaceutical company representation people have come to think of our Prescriber ZRx as the technological solution of the moment for optimal management of medical prescriptions" continued Mr. Marmet.
ZoomMed is also proud to announce the conclusion of two promising business transactions which will allow it, on a short-term basis, to reinforce its marketing strategy. The first agreement, with Berlex, a Montreal pharmaceutical company, concerns the guaranteed purchase of product placement as well as rapid and massive broadcast of information addressed to doctors on the Zrx Prescriber.
With the second agreement, the ZoomMed Equipment division, which specializes in the sale and distribution of medical equipment, has made an important step by signing a first agreement in principle with a corporation benefiting from the great business experience of Groupe Daoust-Forget, a franchisor, for the opening of a "ZOOMCITE" franchise in Laval. In addition, the main "ZOOMCITE" franchise will be opening its doors in November 2006, in Brossard.
These two agreements are the latest additions to the agreements entered into in the recent months regarding the use of the ZRx Prescriber with 10 medical clinics in Quebec and with more than 100 physicians.
For more information on ZOOMMED or the "ZRx Prescriber", please visit our website: www.zoommed.com.
The TSX Venture Exchange does not assume any responsibility as for the relevance or with the exactitude of this press release.
President and Chief Executive Officer
450-678-5457 ext 228